Coronavirus: Here’s everything you need to know about the Moderna vaccine
Eight participants were reported to produce antibodies to COVID-19, in a vaccine trial by Moderna Inc. Image: REUTERS/Brian Snyder
Explore and monitor how COVID-19 is affecting economies, industries and global issues
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
COVID-19
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
Related topics:
The Agenda Weekly
A weekly update of the most important issues driving the global agenda
You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.
More on COVID-19See all
Cassie Werber
March 23, 2023
Samuel J. White and Philippe B. Wilson
March 23, 2023
Zhebin Yu, Erik Melen and Sandra Ekstrom
March 15, 2023
John Gramlich
March 13, 2023
Annalisa Merelli
March 13, 2023
Simon Torkington
March 9, 2023